• No results found

INDUSTRY-ACADEMIC-CLINICAL FORUM

N/A
N/A
Info
Download
Protected

Academic year: 2021

Share "INDUSTRY-ACADEMIC-CLINICAL FORUM"

Copied!
6
0
0

Loading.... (view fulltext now)

Download now ( 6 Page )

Full text

(1)

INDUSTRY-ACADEMIC-CLINICAL FORUM

FUTURE TRENDS IN NANOMEDICINE FOR

DIAGNOSTICS AND THERAPY IN ONCOLOGY

Parc Científic de Barcelona / Barcelona Science Park

25

th

of October of 2012

TABLE OF CONTENTS

Page

Agenda

2

Practical Aspects

3

Order of Presentations

4 – 5

(2)

AGENDA

Date:

25

th

of October of 2012

Place:

Barcelona Science Park - Towers R+D+I

Auditorium in Hall Tower D (ground floor)

4, Baldiri Reixach street

08029 Barcelona

8.30 - 8.55

Registration

8.55 - 9.05

Welcome

Dr. Jesús Purroy, Scientific Director, PCB

Mr. Carlos Lurigados, Project Director, Biocat

9.05 - 9.10

Practical issues for the development of the forum

Dr.

Fernando Santos, Technology Transfer Manager, CIBER-BBN

9.10 - 11.10

Research Groups flash presentations

(5 minutes each)

Please, see order of presentations in page 4

11.10 - 11.30

Coffee break

11.30 - 13.25

Clinical Groups and Companies

flash presentations

(5 minutes each).

Please, see order of presentations in page 5

13.25 – 13.30

Closing remarks

Dr. Pablo Laguna, Scientific Director, CIBER-BBN

13.30 – 14.30

Lunch

(3)

PRACTICAL ASPECTS

1)

Flash Presentations:

a.

English will be used for presentations.

b.

We kindly request to comply to 5 minutes presentations.

c.

No time for questions will exists between the different presentations. Further information

will be provided at one-to-one meetings (partnering).

2)

Partnering Meetings:

a.

Use the partnering tool to request and accept meetings.

Register / Log-in:

b.

Partnering meetings will have duration of 15 minutes. Punctuality and adjustment to the

meeting schedule will be requested.

c.

The time should be sufficient to identify important mutual interests and to organize future

meetings. The partners are encouraged to set-up another date for deeper discussion, if

necessary.

3)

Wi-Fi:

At Barcelona Science Park, on 25

th

of October.

User: ciber-guest

Password: UARS7CXv

4)

Questions to:

Fernando Santos

(4)

University of Barcelona, Barcelona, Spain

2 Centre of Research in Toxicology(Ceretox) Dr. Miquel Borrás

Barcelona, Spain

3 Small System and Biomolecule Physics Group(BIOSMALL-UB) Dr. Félix Ritort

University of Barcelona, CIBER-BBN, Barcelona, Spain

4 Nanobiosensors and Bioanalytical Applications(CIN2-CSIC) Dr. Laura Lechuga

Spanish National Research Council (CSIC), CIBER-BBN, Barcelona, Spain

5 Drug Delivery and Targeting Group (GDLF-HUVH) Dr. Ibane Abásolo

University Hospital Vall d’Hebron, CIBER-BBN, Barcelona, Spain

6 Applied Microbiology Research Group(IBB-UAB) Dr. Esther Vázquez

Biotechnology and Biomedicine Institute (UAB) CIBER-BBN, Barcelona, Spain

7 Oncogenesis and Antitumor Group (GOA-HSCSP) Dr. Ramón Mangues

Research Inst., Hospital de la Santa Cruz y San Pablo, CIBER-BBN, Barcelona, Spain

8 Nucleic Acid Chemistry Group(GQNA-CSIC) Dr. Ramón Eritja

Institute for Advanced Chemistry of Catalonia (CSIC), CIBER-BBN, Barcelona, Spain

9 Nanoparticle and Peptide Chemical Group(IRB) Dr. Miriam Royo

Biomedicine Research Institute, CIBER-BBN, Barcelona, Spain

10 Nanomedicine Group(NANOMED-IBEC) Dr. Josep Samitier

Bioengineering Institute of Catalonia (IBEC), CIBER-BBN, Barcelona, Spain

11 Molecular Nanoscience and Organic Materials Group(NANOMOL-CSIC) Dr. Santiago Sala

Materials Science Institute of Barcelona (CSIC), CIBER-BBN, Barcelona, Spain

12 Nanobiotechnology for Diagnostics (NB4D-IQAC) Dr. Pilar Marco

Institute for Advanced Chemistry of Catalonia (CSIC), CIBER-BBN, Barcelona, Spain

13 Structural Mechanics and Material Modeling Group(GEMM-I3A) Dr. Luis J. Fernández

Engineering Research Inst. of Aragón (U. of Zaragoza), CIBER-BBN, Zaragoza, Spain

14 Multifunctional Molecular Magnetic Materials Group (M4-CSIC) Dr. Fernando Palacio

Materials Science Institute of Aragón (CSIC), CIBER-BBN, Zaragoza, Spain

15 Bioengineering and Telemedicine Group(GBT-UPM) Dr. José Javier Serrano

Universidad Politécnica de Madrid, CIBER-BBN, Madrid, Spain

16 Molecular Immunobiology Laboratory (LIBM-HGUGM) Dr. M. Ángeles Muñoz

University Hospital Gregorio Marañón, CIBER-BBN, Madrid, Spain

17 Dendrimer Group for Biomedical Applications(GDAB-UAH) Dr. Rafael Gómez

University of Alcalá de Henares, CIBER-BBN, Alcalá de Henares (Madrid) Spain

18 Applied Molecular Chemistry Group(IQMA-UPV) Dr. Ramón Martínez

Applied Mol. Chem. Inst. (U. Politécnica de Valencia), CIBER-BBN, Valencia, Spain

19 Group for Advanced Materials and Nanobiotechnology (BIOFORGE-UVA) Dr. Alessandra Girotti

University of Valladolid, CIBER-BBN, Valladolid, Spain

20 CIBER-BBN Research Services Dr. Jesús M. Izco

Zaragoza, Spain

21 Neuroprosthesis and Neuroengineering Research Group (NN-UMH) Dr. Eduardo Fernández

(5)

IRB Lleida, Hospital Arnau de Vilanova, Lleida, Spain

2 Diagnosis and therapy in oncology Dr. David Fuster

IDIBAPS (Hospital Clinic) Barcelona, Spain

3 Biological Markers in Oncology Dr. Rafael Molina

IDIBAPS (Hospital Clinic) Barcelona, Spain

4 Colorectal Cancer Group Dr. Victor Moreno

IDIBELL (Hospital de Bellvitge), Barcelona, Spain

5 Breast Cancer Group Dr. Ander Urruticoechea

IDIBELL (Hospital de Bellvitge), Barcelona, Spain

6 Sarcoma Research Group Dr. Óscar Martínez-Tirado

IDIBELL (Hospital de Bellvitge), Barcelona, Spain

7 Research Unit in Biomedicine and Translational and Pediatrics Oncology Dr. Jaume Reventós

Research Institute, Vall d'Hebron University Hospital, Barcelona, Spain

8 Transbiomed Dr. Marcelo Viegas

Barcelona, Spain

9 VCN Biosciences Dr. Manel Cascalló

L’Hospitalet de Llobregat (Barcelona) Spain

10 Advanced Marker Discovery (AMADIX) Dr. Ana Martín

Madrid, Spain

11 TCD Pharma Dr. Nicholas Occleston

Valladolid, Spain

12 Apointech Dr. Emmanuel Fajardo

Villamayor (Salamanca), Spain

13 Argon Pharma Dr. Óscar Peña

Barcelona, Spain

14 BCN Peptides. Dr. Lluis Riera

Sant Quintí de Mediona (Barcelona) Spain

15 Endor Nanotechnologies Dr. Luciano Sobrevals

Barcelona, Spain

16 Ferrer Group Dr. Andrés G. Fernández

Barcelona, Spain

17 Gendiag Dr. Eduardo Salas

Barcelona, Spain

18 Lykera Biomed Dr. Francesc Mitjans

Barcelona, Spain

19 NTE-Sener Dr. Josep M. Escuer

Cerdanyola del Vallès (Barcelona) Spain

20 Vivia Biotech Dr. Resu Alloza

(6)

Tower I

Ground floor

Elevators

to 3

rd

floor Tower I

AUDITORIUM

Morning: Presentations Afernoon: PARTNERING

Tables 19-22

Room 3

Tables 2-3

Room 1

UNavailable

Elevators

Tower I

3

rd

floor

Tower D

Ground floor

Room 4

UNavailable

Room 2

Table 1

Room 2

Tables 9-10

Room 1

Tables 4-8

Room 3

Table 11

Room 4

Tables 12-18

Tower I

Ground floor

References

Download now ( PDF - 6 Page - 200.12 KB )

Related documents

Cisco Content Services Switch Content Load-Balancing Configuration Guide

Note In a GSLB environment with the absolute load calculation method configured, if a service exceeds its maximum connections limit, exceeds the local load threshold, or has

Brian C. Cadena. University of Colorado - Boulder. Assistant Professor, Department of Economics, University of Colorado at Boulder (2008-)

Referee: American Economic Review, BEJEAP, Demography, Economic Inquiry, The Economic Journal, Economics of Education Review, Industrial and Labor Relations Review,

Working Paper Consumer absenteeism, search, advertising, and sticky prices. Working Papers, Bar-Ilan University, Department of Economics, No.

I shall show that if A; and are su¢ ciently large (that is, the cost of advertising is high and costs don’t change too frequently), then all stationary equilibria in which l

Utilization of Income Tax Credits by Low-Income Individuals

data, Scholz (1994) finds participation rates between 122 and 131 percent, sug- gesting that a large number of technically ineligible taxpayers file for and receive the

Turbine Blade Tip Leakage Flow Control by Unsteady Periodic Wakes of Upstream Blade Row

The flow field at the exit of the cascade showed a decrease both in tip leakage vortex and passage vortex strength and loss due to upstream periodic wakes transport. There is

Intelligent Semantic Web Search Engines: A Brief Survey

Currently many of semantic search engines are developed and implemented in different working environments, and these mechanisms can be put into use to realize present search

Videoconferencing in Legal Procedures. What we do in The Netherlands and in Europa

possible to alternate between videoconferencing and non-videoconferencing fast possible to change videoconferencing settings between cases fast (~1 minute) reliable to